Keyphrases
Meta-analysis
100%
Immune Cells
100%
Prognostic Value
100%
Tumor Microenvironment
100%
Early-stage Lung Cancer
100%
Natural Killer Cells
50%
CD20+ B Cells
50%
Cytotoxic CD8+ T Cells
50%
Regulatory T (Treg) Cells
50%
Clinical Covariates
50%
FoxP3+
50%
Lung Cancer
25%
Significant Risk Factors
25%
Systematic Literature Review
25%
Clinical Outcomes
25%
Macrophages
25%
Cell-to-cell
25%
CD4+ T Helper Cells
25%
Immune Parameters
25%
CD56+
25%
Recurrence Risk
25%
Mast Cells
25%
U.S. National Library of Medicine
25%
Systemic Treatment
25%
CD3+ T Cells
25%
CD57
25%
CD68+
25%
PRISMA Guidelines
25%
Immune Tumor Microenvironment
25%
Cell Components
25%
Resectable Lung Cancer
25%
Medicine and Dentistry
Lung Cancer
100%
Meta-Analysis
100%
Immunocompetent Cell
100%
Tumor Microenvironment
100%
Non Small Cell Lung Cancer
75%
B Cell
50%
T-Helper Cell
50%
Natural Killer Cell
50%
CD8 Antigen
50%
Cytotoxic T-Cell
50%
CD20
50%
Regulatory T Cell
50%
Recurrent Disease
25%
Immunotherapy
25%
Biological Marker
25%
Tumor Immune Microenvironment
25%
Macrophage
25%
Medicine
25%
Systemic Therapy
25%
Mast Cell
25%
Chlordane
25%
Cell Component
25%
CD3 Antigen
25%
Immunology and Microbiology
Immunocompetent Cell
100%
B Cell
50%
Natural Killer Cell
50%
CD8
50%
CD20
50%
Cytotoxic T Cell
50%
Regulatory T Cell
50%
Immunotherapy
25%
Macrophage
25%
T Helper Cell
25%
T-Helper Cell
25%
Mast Cell
25%
Immunity
25%
Cell Component
25%
CD68
25%
CD3 Antigen
25%